1. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network
   Qingyu Xu et al, 2023, Frontiers in Genetics CrossRef
2. ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
   Qihang Peng et al, 2023, International Journal of Molecular Sciences CrossRef
3. MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma
   Guo-Sheng Li et al, 2024, Cancer Control CrossRef
4. The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature
   Albina Fejza et al, 2023, Frontiers in Immunology CrossRef
5. Transcriptomics integrated with metabolomics unravels the interweaving of inflammatory response and 1-stearoyl-2-arachidonoyl-sn-glycerol metabolic disorder in chronic cadmium exposure-induced hepatotoxicity
   Rongrong Hao et al, 2023, Environmental Toxicology and Pharmacology CrossRef
6. Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation
   Qi-xin Lian et al, 2023, PeerJ CrossRef
7. Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
   Kai Gan et al, 2022, Frontiers in Genetics CrossRef
8. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses
   Yan Wang et al, 2023, Mediators of Inflammation CrossRef
9. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma
   Weipu Mao et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
10. Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma
    Yushen Huang et al, 2022, Frontiers in Genetics CrossRef